Anti-Allergy Agents
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (30 May 2013) | Viewed by 191
Special Issue Editors
Interests: IgE; tetracycline; minocycline; complement; MAP kinase; neural control of IgE responses
Interests: IgE; allergy; asthma; food allergy; HIV-1; thymus; brain; magnetic stimulation; neuropeptides; Peyer’s patches; bacterial cell wall components; peptidoglycan; tetracycline; minocycline; chemically modified tetracycine
Special Issue Information
Dear Colleagues,
Investigations into pathophysiologic mechanisms are revealing the pieces of the puzzle that is allergy, with new potential therapeutic targets emerging. This issue of Pharmaceuticals will present recent developments in our understanding of the etiopathogenesis of IgE responses, and provide a better understanding of present and potential treatments for this area of hypersensitivity which can affect more than 25% of the general population.
Dr. Rauno Joks
Dr. Helen G. Durkin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunolgobulin E
- atopy
- allergy
- Corticosteroid
- beta-agonist
- anti-leukotriene therapy
- omalizumab
- mast cell
- anti-interleukin-5 monoclonal therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
